These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19165552)

  • 1. Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.
    Marmolino D; Acquaviva F
    Cerebellum; 2009 Sep; 8(3):245-59. PubMed ID: 19165552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.
    Chan PK; Torres R; Yandim C; Law PP; Khadayate S; Mauri M; Grosan C; Chapman-Rothe N; Giunti P; Pook M; Festenstein R
    Hum Mol Genet; 2013 Jul; 22(13):2662-75. PubMed ID: 23474817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.
    Lufino MM; Silva AM; Németh AH; Alegre-Abarrategui J; Russell AJ; Wade-Martins R
    Hum Mol Genet; 2013 Dec; 22(25):5173-87. PubMed ID: 23943791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
    Polak U; Li Y; Butler JS; Napierala M
    Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia.
    Gottesfeld JM
    Neurotherapeutics; 2019 Oct; 16(4):1032-1049. PubMed ID: 31317428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Friedreich's ataxia--a case of aberrant transcription termination?
    Butler JS; Napierala M
    Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-based approaches toward Friedreich ataxia therapeutics.
    Hebert MD; Whittom AA
    Cell Mol Life Sci; 2007 Dec; 64(23):3034-43. PubMed ID: 17828464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia.
    Gottesfeld JM; Rusche JR; Pandolfo M
    J Neurochem; 2013 Aug; 126 Suppl 1(0 1):147-54. PubMed ID: 23859350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
    Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
    Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
    Rai M; Soragni E; Chou CJ; Barnes G; Jones S; Rusche JR; Gottesfeld JM; Pandolfo M
    PLoS One; 2010 Jan; 5(1):e8825. PubMed ID: 20098685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
    Herman D; Jenssen K; Burnett R; Soragni E; Perlman SL; Gottesfeld JM
    Nat Chem Biol; 2006 Oct; 2(10):551-8. PubMed ID: 16921367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia.
    Kim E; Napierala M; Dent SY
    Nucleic Acids Res; 2011 Oct; 39(19):8366-77. PubMed ID: 21745819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich's Ataxia.
    Lai Y; Diaz N; Armbrister R; Agoulnik I; Liu Y
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's ataxia: new insights.
    Krasilnikova MM; Humphries CL; Shinsky EM
    Emerg Top Life Sci; 2023 Dec; 7(3):313-323. PubMed ID: 37698160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
    Vilema-Enríquez G; Quinlan R; Kilfeather P; Mazzone R; Saqlain S; Del Molino Del Barrio I; Donato A; Corda G; Li F; Vedadi M; Németh AH; Brennan PE; Wade-Martins R
    J Biol Chem; 2020 Dec; 295(52):17973-17985. PubMed ID: 33028632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Regulation of the Disease-Causing Gene
    Dong YN; Mercado-Ayón E; Coulman J; Flatley L; Ngaba LV; Adeshina MW; Lynch DR
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia.
    Chutake YK; Costello WN; Lam C; Bidichandani SI
    J Biol Chem; 2014 May; 289(22):15194-202. PubMed ID: 24737321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.